ABPath Anatomic Pathology common mistakes
ABPath Anatomic Pathology · Understand the traps and how to avoid them.
Selecting the answer that matches a single remembered keyword or buzzword in the stem (e.g., 'Call-Exner bodies,' 'orphan Annie eyes') without checking whether the remaining clinical and histologic descriptors in the stem are compatible with that entity.
Years of residency pattern-recognition training condition candidates to trigger on one pathognomonic feature; the exam deliberately pairs a familiar buzzword with one or two discordant features (wrong age, wrong site, wrong growth pattern) so that keyword matching produces a plausible but wrong choice.
What to do instead
Adopt a forced checklist routine: before answering, write down the 3-4 required criteria for the entity the buzzword suggests and explicitly verify each against the stem. If any criterion fails, generate a second differential and choose the option that satisfies the greatest number of stated features rather than the most familiar name.
Applying a remembered staging or grading schema from an older edition (e.g., a prior Gleason/ISUP grouping, an outdated breast or colorectal pT rule, an older FIGO stage) instead of the currently accepted version, or mixing elements from two different systems in one answer.
Study material from training years persists in memory and many review resources lag behind edition changes; candidates also learn staging from surgical experience where the practical rule of thumb differs from the formal published criteria.
What to do instead
Rebuild a one-page staging/grading summary directly from the current AJCC/WHO/CAP sources, annotate each line with the edition and year, and re-derive every practice question answer from that sheet. Where two systems coexist (e.g., grade vs stage, FIGO vs TNM), explicitly label which question is being asked.
Placing a cytology case in the wrong reporting category at a defined boundary (e.g., calling a sparse, mildly atypical follicular cell population AUS/FLUS when the features meet benign or suspicious criteria; calling equivocal squamous atypia LSIL or ASC-US inconsistently) or ignoring the specified adequacy threshold for the specimen type.
Category boundaries are defined by reproducibility studies and consensus criteria rather than by an absolute biologic threshold, so candidates default to personal gestalt; adequacy rules also differ by specimen type (thyroid FNA vs urine vs CSF vs serous fluid) and are easily conflated.
What to do instead
Memorize the written definition of each category in the applicable reporting system together with its stated risk of malignancy, then practice a block of deliberately borderline cases and justify each placement in writing using the definition. Keep a separate per-specimen adequacy table (minimum cellularity, required cell types, preservative and volume constraints) and consult it for every adequacy question.
Judging adequacy or negativity of a cytology specimen by the number of cells present alone, without confirming that the diagnostically relevant cell population or anatomic site was actually sampled (e.g., acellular cyst fluid, bronchial washings with only squamous contaminants, urine with only umbrella cells).
Candidates equate cellularity with adequacy, and the stem often supplies an impressive cell count that consists entirely of the wrong cell type; adequacy is a site-specific requirement for the target cells, not a global count.
What to do instead
For every adequacy question, state aloud what the target cell population is, then ask whether that population is represented and whether the volume/preservation criteria are met. Learn the standard adequacy statements for each specimen type and treat contaminant-only specimens as nondiagnostic regardless of cellularity.
On forensic and hospital autopsy questions, conflating cause of death, mechanism of death, and manner of death, or listing the anatomic finding as the cause when the stem asks for the mechanism (and vice versa); also certifying a cause without reconciling the clinical history, toxicology, and scene information provided.
Gross pathology training emphasizes anatomic diagnoses, while death certification requires a formal chain from underlying cause to mechanism to manner; the distinctions are taught briefly and rarely practiced under exam-style constraints, and the wording of the question often does not announce which of the three is wanted.
What to do instead
Before selecting an answer, write three labeled lines: underlying cause, mechanism (the physiologic derangement, e.g., arrhythmia, exsanguination), and manner (natural, accident, homicide, suicide, undetermined). Then match the question's wording to the correct line. Practice by drafting complete death certificates for 10-15 classic scenarios and comparing against standard references.
Interpreting postmortem change, resuscitation or medical intervention artifact, or autolysis as antemortem disease, and failing to request the ancillary autopsy study that would resolve the question (vitreous chemistry, postmortem imaging, cultures, toxicology, genetic testing for sudden cardiac death).
These findings are uncommon in surgical practice and are typically learned from a small number of autopsy rotations; postmortem settling, gastric autolysis, rib fractures from CPR, and line-placement injuries closely mimic genuine pathology when seen out of context.
What to do instead
Use a systematic autopsy checklist that includes a dedicated artifact/postmortem-change review step, and build a short table pairing each ambiguous finding with the ancillary test that distinguishes it (e.g., vitreous electrolytes for dehydration vs urea cycle defect, postmortem CT for fractures, molecular testing for channelopathy). Rehearse this table on practice vignettes.
Over-reading immunohistochemistry by treating a marker as binary positive or negative without checking subcellular localization, expected distribution, and intensity, or by accepting a single 'positive' stain as diagnostic when it lacks the required sensitivity and specificity for that site.
Board review compresses IHC into memorized positive/negative associations, so candidates forget that nuclear versus cytoplasmic versus membranous staining, diffuse versus patchy distribution, and weak versus strong intensity change the interpretation entirely; a single marker is almost never sufficient in a well-constructed question.
What to do instead
For each commonly tested marker, memorize the expected compartment (nuclear, cytoplasmic, membranous), the normal internal control, and the typical pattern in the tumor. For each question, name the panel, state what a true positive must look like, and require at least one corroborating marker and one negative marker before committing to a diagnosis.
Mishandling molecular results by treating a variant of unknown significance as pathogenic, failing to distinguish a germline from a somatic finding, ignoring variant allele fraction or tumor purity, or confusing a break-apart FISH signal pattern with amplification.
Molecular reports are read clinically in a binary 'mutation found/not found' fashion, and candidates rarely see the interpretive caveats; the underlying technologies (sequencing depth, allele fraction, fusion probes) each have distinct failure modes that exam questions probe directly.
What to do instead
Learn the standard reporting vocabulary and what each result does and does not establish: pathogenic versus likely pathogenic versus VUS, germline (near 50% allele fraction, paired normal) versus somatic, and break-apart (separated signals indicating rearrangement) versus amplification (increased copy number). Practice interpreting full sample reports rather than one-line results.
Conflating the requirements of different oversight bodies and standards (CLIA, CAP accreditation checklists, Joint Commission, state licensure) on questions about test validation, proficiency testing, personnel qualifications, or assay verification, and answering with a requirement that belongs to a different authority or to a different test category.
The regulations overlap substantially in everyday practice, so a rule remembered from one context feels universally applicable; candidates also memorize isolated facts without a framework showing which body governs which activity and what changes for laboratory-developed tests versus FDA-cleared assays.
What to do instead
Build a comparative table with one row per activity (method validation, verification, proficiency testing, director qualifications, LDT oversight, turnaround-time monitoring) and one column per authority, filling it only from primary documents. For each practice question, first identify the governing authority named or implied, then answer from that column.
Answering laboratory informatics questions with generic information-technology reasoning instead of pathology-specific requirements, for example treating an HL7 interface, synoptic reporting template, specimen barcoding chain, digital pathology whole-slide imaging validation, or PHI handling question as though any standard solution would do.
Informatics is the domain least represented in anatomic pathology training, so candidates fall back on consumer-level computer knowledge and miss that the correct answer depends on pathology workflow rules such as specimen identity reconciliation at every handoff, required synoptic data elements, and validation of digital systems against glass slides before clinical use.
What to do instead
Study the CAP informatics and laboratory accreditation checklist items and the standard synoptic reporting datasets as primary material, then map each to a concrete workflow failure it prevents. For every informatics question, ask what pathology-specific risk (misidentification, data loss, unsigned report, unvalidated imaging) the option addresses, and reject options that only sound technically sophisticated.